Results of Switching from Pro Re Nata to Treat-and-Extend Regimen in Treatment of Patients with Type 3 Neovascularization.

Conclusions: In type 3 neovascularization, visual acuity was maintained for an average of 20.5 months after switching from the PRN regimen to the TAE regimen. Further studies with larger study populations and controlled study designs are required to confirm our findings. PMID: 31814497 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31814497?dopt=Abstract

Source: Seminars in Ophthalmology - December 10, 2019 Category: Opthalmology Tags: Semin Ophthalmol Source Type: research

More News: Eyes | Opthalmology | Study